A novel methylation signature predicts radiotherapy sensitivity in glioma

Glioblastoma (GBM) is the most common and malignant cancer of the central nervous system, and radiotherapy is widely applied in GBM treatment; however, the sensitivity to radiotherapy varies in different patients. To solve this clinical dilemma, a radiosensitivity prediction signature was constructe...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuemei, Li, Guanzhang, Shi, Zhongfang, Yan, Xu, Wang, Zhiliang, Jiang, Haoyu, Chen, Ye, Li, Renpeng, Zhai, You, Chang, Yuanhao, Zhang, Wei, Yuan, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683673/
https://www.ncbi.nlm.nih.gov/pubmed/33230136
http://dx.doi.org/10.1038/s41598-020-77259-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683673/
https://www.ncbi.nlm.nih.gov/pubmed/33230136
http://dx.doi.org/10.1038/s41598-020-77259-9

Ejemplares similares